About Labiana S.A.

Company Description

More than 460 people work daily to offer a wide range of Contract Developments and Manufacturing (CDMO) services as well as proprietary animal health and human medicine products.

Our continual search for operational excellence is patent in the different areas of activity in which LABIANA excels, such as:

- GMP manufacturer for EU animal and human health industries
- Manufacturer specialized in sterile and lyophilized dosage forms
- A source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol
- Creator of a wide range of own animal health products, with more than 640 MAs (Marketing Authorisations) worldwide

Year founded

2012

Served area

Worldwide

Headquarters

Europa 34 Pozuelo de Alarcรณn, 28023 Madrid โ€“ Spain

Filings & Publications

Sign up and we will inform you!

Insider Trades

Sign up and we will inform you!

Shareholder information

Shares outstanding

7,220,000

IPO

June 24, 2022

Stock exchange(s)

Bolsa de Madrid

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.